Literature DB >> 22248516

Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients.

Jordan A Holmes1, William R Carpenter, Yang Wu, Laura H Hendrix, Sharon Peacock, Mark Massing, Anna P Schenck, Anne-Marie Meyer, Kevin Diao, Stephanie B Wheeler, Paul A Godley, Karyn B Stitzenberg, Ronald C Chen.   

Abstract

PURPOSE: We examined whether an increased distance to a urologist is associated with a delayed diagnosis of prostate cancer among black and white patients, as manifested by higher risk disease at diagnosis.
MATERIALS AND METHODS: North Carolina Central Cancer Registry data were linked to Medicare claims for patients with incident prostate cancer diagnosed in 2004 to 2005. Straight-line distances were calculated from the patient home to the nearest urologist. Race stratified multivariate ordinal logistic regression was used to examine the association between distance to a urologist and prostate cancer risk group (low, intermediate, high or very high/metastasis) at diagnosis for black and white patients while accounting for age, comorbidity, marital status and diagnosis year. An overall model was then used to examine the distance × race interaction effect.
RESULTS: Included in analysis were 1,720 white and 531 black men. In the overall cohort the high risk cancer rate increased monotonically with distance to a urologist, including 40% for 0 to 10, 45% for 11 to 20 and 57% for greater than 20 miles. Correspondingly the low risk cancer rate decreased with longer distance. On race stratified multivariate analysis longer distance was associated with higher risk prostate cancer for white and black patients (p = 0.04 and <0.01, respectively) but the effect was larger in the latter group. The distance × race interaction term was significant in the overall model (p = 0.03).
CONCLUSIONS: Longer distance to a urologist may disproportionally impact black patients. Decreasing modifiable barriers to health care access, such as distance to care, may decrease racial disparities in prostate cancer.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22248516     DOI: 10.1016/j.juro.2011.10.156

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  Influence of travel burden on tumor classification and survival of head and neck cancer patients.

Authors:  J M Vahl; A von Witzleben; C Welke; J Doescher; M N Theodoraki; M Brand; P J Schuler; J Greve; T K Hoffmann; S Laban
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-20       Impact factor: 2.503

2.  Racial Differences in Geographic Access to Medical Care as Measured by Patient Report and Geographic Information Systems.

Authors:  Michelle S Wong; David T Grande; Nandita Mitra; Archana Radhakrishnan; Charles C Branas; Katelyn R Ward; Craig E Pollack
Journal:  Med Care       Date:  2017-09       Impact factor: 2.983

3.  Travel time to provider is associated with advanced stage at diagnosis among low income head and neck squamous cell carcinoma patients in North Carolina.

Authors:  Douglas R Farquhar; Maheer M Masood; Nicholas R Lenze; Philip McDaniel; Angela Mazul; Siddharth Sheth; Adam M Zanation; Trevor G Hackman; Mark Weissler; Jose P Zevallos; Andrew F Olshan
Journal:  Oral Oncol       Date:  2019-01-02       Impact factor: 5.337

4.  Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent's University Hospital, Dublin (2009-2011).

Authors:  F O'Kelly; A Z Thomas; D Murray; P Lee; R F O'Carroll; P Nicholson; H Forristal; N Swan; D Galvin; D Mulvin; D M Quinlan
Journal:  Ir J Med Sci       Date:  2013-02-17       Impact factor: 1.568

5.  Big data for population-based cancer research: the integrated cancer information and surveillance system.

Authors:  Anne-Marie Meyer; Andrew F Olshan; Laura Green; Adrian Meyer; Stephanie B Wheeler; Ethan Basch; William R Carpenter
Journal:  N C Med J       Date:  2014 Jul-Aug

6.  Ethnic disparities in adherence to breast cancer survivorship surveillance care.

Authors:  Pragati S Advani; Jun Ying; Richard Theriault; Amal Melhem-Bertrand; Stacy Moulder; Isabelle Bedrosian; Welela Tereffe; Shon Black; Tunghi May Pini; Abenaa M Brewster
Journal:  Cancer       Date:  2013-11-20       Impact factor: 6.860

7.  Increasing Urologic Care Ratios: Implications of Male Patient Care in Florida.

Authors:  Walker Talton; Hanna Lindner; Michael J Rovito
Journal:  Am J Mens Health       Date:  2016-08-15

8.  USIDNET: a strategy to build a community of clinical immunologists.

Authors:  Kathleen E Sullivan; Jennifer M Puck; Luigi D Notarangelo; Ramsay Fuleihan; Tara Caulder; Connie Wang; Marcia Boyle; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2014-04-08       Impact factor: 8.317

9.  The association between calcium channel blocker use and prostate cancer outcome.

Authors:  Michael A Poch; Diana Mehedint; Dawn J Green; Rochelle Payne-Ondracek; Elizabeth T H Fontham; Jeannette T Bensen; Kristopher Attwood; Gregory E Wilding; Khurshid A Guru; Willie Underwood; James L Mohler; Hannelore V Heemers
Journal:  Prostate       Date:  2012-12-31       Impact factor: 4.104

10.  Physician-reported barriers to referring cancer patients to specialists: prevalence, factors, and association with career satisfaction.

Authors:  Daniel H Kwon; Diana M Tisnado; Nancy L Keating; Carrie N Klabunde; John L Adams; Afshin Rastegar; Mark C Hornbrook; Katherine L Kahn
Journal:  Cancer       Date:  2014-09-05       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.